Form 4 for AORT ARTIVION, INC.
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001653206-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-14 | 2025-08-12 | AORT | Davis John E | Chief Commercial Off | S - Sale+OE | $43.67 | -10.8K | 208.8K | -5% | -$471.7K |
| D | 2025-08-14 | 2025-08-12 | AORT | Davis John E | Chief Commercial Off | M - OptEx | $26.24 | +10.8K | 219.6K | +5% | +$283.4K |
| D | 2025-08-14 | 2025-08-12 | AORT | Davis John E | Chief Commercial Off | M - OptEx | $0.00 | -10.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | S | D | 10,802 | $43.67 | 208,778 | D | — | — | (F1) Reflects weighted average price. Range of prices were between $43.470 to $43.835. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-08-12 | M | A | 10,802 | $26.24 | 219,580 | D | — | — | |
| 3 | Derivative | Stock Options (Right to buy) | 2025-08-12 | M | D | 10,802 | $0.00 | 0 | D | $26.24 · 2021-02-19 to 2027-02-19 | 10,802 Common Stock | (F2) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 19, 2021. |